At this time, posts about Gwangdong Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have net sold 45,000 shares of Gwangdong Pharmaceutical, and institutions have net sold 2,000 shares, according to preliminary data. Gwangdong Pharmaceutical is known as a pharmaceutical company specializing in herbal products and health beverages.


As of 11:30 AM on the 8th, Gwangdong Pharmaceutical's stock price is 11,050 KRW, up 5.74% from the previous day, with a trading volume of 7,548,086 shares, which is 178.54% of the 5-day average trading volume. On October 7th, Gwangdong Pharmaceutical became a market issue with the news of 'Betadine coronavirus 99.9% eradication effect↑.'


In addition to Gwangdong Pharmaceutical, posts by investors are also rapidly increasing for Dongseo (026960), Mobile Appliance (087260), and Signetics (033170).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing